Dare Bioscience (DARE) Market Capitalization (2017 - 2026)

Dare Bioscience (DARE) has reported Market Capitalization for 10 consecutive years, with $32.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 48.3% year-over-year to $32.0 million; the trailing twelve-month figure through Jun 2026 stood at $32.0 million (up 48.3% YoY), and the FY2025 full-year result was $21.6 million, down 20.52% from the prior year.
• Market Capitalization improved to $32.0 million in Q2 2026 per DARE's latest filing, from $21.6 million in the prior quarter.
• Across five years, Market Capitalization topped out at $125.1 million in Q1 2022 and bottomed at $21.6 million in Q4 2025.
• Historically, Market Capitalization has averaged $52.7 million across 5 years, with a median of $34.5 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Market Capitalization soared 56.43% in 2022, then plunged 56.28% in 2024.
• Over 5 years, Market Capitalization stood at $70.4 million in 2022, then slumped by 56.12% to $30.9 million in 2023, then slipped by 12.13% to $27.1 million in 2024, then fell by 20.52% to $21.6 million in 2025, then jumped by 48.36% to $32.0 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $32.0 million, $21.6 million, and $29.3 million for Q2 2026, Q4 2025, and Q3 2025 respectively.